BioMarin Pharmaceutical | BMRN - Заемный капитал

Биржевая цена
53.99
Изменение за день
0.69 1.29%
Ежемесячно
-1.46%
Ежегодный
-15.23%
Q2 прогноз
52.04




Заемный капитал Изменить Дата
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
Incyte USD 29.41M 785K 2026-03
Insmed USD 540.96M 1.24M 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Moderna USD 610M 584M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 150.06M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03